C2, C3, C5, and MBL levels did not correlate either with disease severity evaluated by MG-specific Activities of Daily Living (MG-ADL) and MG Composite (MGC) scores or with anti-AChR Ab titers (data not shown). This evidence concerns the gene MBL2 and myasthenia gravis.